General practitioners' decision making about primary prevention of cardiovascular disease in older adults: A qualitative study

PLoS ONE

Volumn 12, Issue 1, 2017, Pages

  Jansen, Jesse ^a,b   McKinn, Shannon ^a,b   Bonner, Carissa ^a,b   Irwig, Les ^a   Doust, Jenny ^a,c   Glasziou, Paul ^a,c   Bell, Katy ^a   Naganathan, Vasi ^b   McCaffery, Kirsten ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c BOND UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; DRUG THERAPY; FEMALE; FRAILTY; GENERAL PRACTITIONER; HUMAN; KNOWLEDGE; LIFE EXPECTANCY; LIFESTYLE MODIFICATION; MALE; MEDICAL DECISION MAKING; NURSING HOME PATIENT; PATIENT CARE; PHYSICIAN ATTITUDE; POLYPHARMACY; PRACTICE GUIDELINE; PRIMARY PREVENTION; QUALITATIVE RESEARCH; RISK MANAGEMENT; CARDIOVASCULAR DISEASES; CLINICAL DECISION MAKING; COMPLICATION; DOCTOR PATIENT RELATION; FRAIL ELDERLY; HEALTH PERSONNEL ATTITUDE; HEALTH STATUS; LIFESTYLE; NEW SOUTH WALES; PROCEDURES; PSYCHOLOGY; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATTITUDE OF HEALTH PERSONNEL; CARDIOVASCULAR DISEASES; CLINICAL DECISION-MAKING; FEMALE; FRAIL ELDERLY; GENERAL PRACTITIONERS; HEALTH STATUS; HUMANS; LIFE EXPECTANCY; LIFE STYLE; MALE; NEW SOUTH WALES; PHYSICIAN-PATIENT RELATIONS; PRIMARY PREVENTION; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTORS;

EID: 85009373053     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0170228     Document Type: Article

References (48)

1. Scott IA, Guyatt GH. Cautionary tales in the interpretation of clinical studies involving older persons. Arch Intern Med. 2010; 170(7): 587-595. doi: 10.1001/archinternmed.2010.18 PMID: 20386001
2. Benetos A, Rossignol P, Cherubini A, Joly L, Grodzicki T, Rajkumar C, et al. Polypharmacy in the aging patient: management of hypertension in octogenarians. JAMA. 2015; 314(2): 170-180. doi: 10.1001/jama.2015.7517 PMID: 26172896
3. Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012; 65(9): 989-995. doi: 10.1016/j.jclinepi.2012.02.018 PMID: 22742913
4. Tinetti ME, Bogardus ST Jr., Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004; 351(27): 2870-2874. doi: 10.1056/NEJMsb042458 PMID: 15625341
5. Fried TR, Tinetti ME, Iannone L, O'Leary JR, Towle V, Van Ness PH. Health outcome prioritization as a tool for decision making among older persons with multiple chronic conditions. Arch Intern Med. 2011; 171(20): 1854-1856. doi: 10.1001/archinternmed.2011.424 PMID: 21949032
6. Fried TR, McGraw S, Agostini JV, Tinetti ME. Views of older persons with multiple morbidities on competing outcomes and clinical decision-making. J Am Geriatr Soc. 2008; 56(10): 1839-1844. doi: 10. 1111/j.1532-5415.2008.01923.x PMID: 18771453
7. Tinetti ME, McAvay GJ, Fried TR, Foody JM, Bianco L, Ginter S, et al. Development of a tool for eliciting patient priority from among competing cardiovascular disease, medication-symptoms, and fall injury outcomes. J Am Geriatr Soc. 2008; 56(4): 730-736. doi: 10.1111/j.1532-5415.2007.01627.x PMID: 18266842
8. Weiner M, Wells S, Kerse N. Perspectives of general practitioners towards evaluation and treatment of cardiovascular disease among older people. J Prim Health Care. 2009; 1(3): 198-206. PMID: 20690383
9. Dalton AF, Golin CE, Esserman D, Pignone MP, Pathman DE, Lewis CL. Relationship between physicians' uncertainty about clinical assessments and patient-centered recommendations for colorectal cancer screening in the elderly. Med Decis Making. 2015; 35(4): 458-466. doi: 10.1177/0272989X15572828 PMID: 25712448
10. Schuling J, Gebben H, Veehof LJ, Haaijer-Ruskamp FM. Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study. BMC Fam Pract. 2012; 13: 56. doi: 10.1186/1471-2296-13-56 PMID: 22697490
11. Anthierens S, Tansens A, Petrovic M, Christiaens T. Qualitative insights into general practitioners views on polypharmacy. BMC Fam Pract. 2010; 11: 65. doi: 10.1186/1471-2296-11-65 PMID: 20840795
12. Petersen LK, Christensen K, Kragstrup J. Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+year olds. Age Ageing. 2010; 39(6): 674-680. doi: 10.1093/ageing/afq129 PMID: 20952373
13. Gu Q, Burt VL, Dillon CF, Yoon S. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010. Circulation. 2012; 126(17): 2105-2114. doi: 10.1161/CIRCULATIONAHA.112. 096156 PMID: 23091084
14. Rossello X, Pocock SJ, Julian DG. Long-Term Use of Cardiovascular Drugs Challenges for Research and for Patient Care. Journal Am Coll Cardiol. 2015; 66(11): 1273-1285.
15. Russell BJ, Rowett D, Abernethy AP, Currow DC. Prescribing for comorbid disease in a palliative population: focus on the use of lipid-lowering medications. Intern Med J. 2014; 44(2): 177-184. doi: 10.1111/imj.12340 PMID: 24341863
16. Ferket BS, Colkesen EB, Visser JJ, Spronk S, Kraaijenhagen RA, Steyerberg EW, et al. Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check? Arch Intern Med. 2010; 170(1): 27-40. doi: 10.1001/archinternmed.2009.434 PMID: 20065196
17. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008; 117(6): 743-753. doi: 10.1161/CIRCULATIONAHA.107.699579 PMID: 18212285
18. Jackson R. Cardiovascular risk prediction: are we there yet? Heart. 2008; 94(1): 1-3. doi: 10.1136/hrt. 2007.138040 PMID: 18083943
19. Liew SM, Jackson R, Mant D, Glasziou P. Should identical CVD risks in young and old patients be managed identically? Results from two models. BMJ Open. 2012; 2(2): e000728. doi: 10.1136/bmjopen-2011-000728 PMID: 22382122
20. Vollrath AM, Sinclair C, Hallenbeck J. Discontinuing cardiovascular medications at the end of life: lipidlowering agents. J Palliat Med. 2005; 8(4): 876-881. doi: 10.1089/jpm.2005.8.876 PMID: 16128666
21. Holmes HM, Todd A. Evidence-based deprescribing of statins in patients with advanced illness. JAMA Intern Med. 2015; 175(5): 701-702. doi: 10.1001/jamainternmed.2015.0328 PMID: 25799203
22. American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the American Geriatrics Society. J Am Geriatr Soc. 2012; 60(10): 1957-1968. doi: 10.1111/j.1532-5415.2012.04187. x PMID: 22994844
23. Leppin AL, Montori VM, Gionfriddo MR. Minimally disruptive medicine: a pragmatically comprehensive model for delivering care to patients with multiple chronic conditions. Healthcare. 2015; 3(1): 50-63. doi: 10.3390/healthcare3010050 PMID: 27417747
24. Muth C, van den Akker M, Blom JW, Mallen CD, Rochon J, Schellevis FG et al. The Ariadne principles: how to handle multimorbidity in primary care consultations. BMC Med. 2014; 12(1): 223.
25. Jansen J, McKinn S, Bonner C, Irwig L, Doust J, Glasziou P, et al. Systematic review of clinical practice guidelines recommendations about primary cardiovascular disease prevention for older adults. BMC Fam Pract. 2015; 16(1): 104.
26. Vitry AI, Zhang Y. Quality of Australian clinical guidelines and relevance to the care of older people with multiple comorbid conditions. M J Aust. 2008; 189(7): 360-365.
27. Mutasingwa DR, Ge H, Upshur REG. How applicable are clinical practice guidelines to elderly patients with comorbidities? Can Fam Physician. 2011; 57(7): e253-e262. PMID: 21753084
28. Wyatt KD, Stuart LM, Brito JP, Carranza Leon B, Domecq JP, Prutsky GJ, et al. Out of context: clinical practice guidelines and patients with multiple chronic conditions: a systematic review. Med Care. 2014; 52 Suppl 3: S92-S100.
29. Christian AH, Mills T, Simpson SL, Mosca L. Quality of cardiovascular disease preventive care and physician/practice characteristics. J Gen Intern Med. 2006; 21(3): 231-237. doi: 10.1111/j.1525-1497. 2006.00331.x PMID: 16637822
30. Doroodchi H, Abdolrasulnia M, Foster JA, Foster E, Turakhia MP, Skelding KA, et al. Knowledge and attitudes of primary care physicians in the management of patients at risk for cardiovascular events. BMC Fam Pract. 2008; 9: 42. doi: 10.1186/1471-2296-9-42 PMID: 18611255
31. Schmittdiel JA, Traylor A, Uratsu CS, Mangione CM, Ferrara A, Subramanian U. The association of patient-physician gender concordance with cardiovascular disease risk factor control and treatment in diabetes. J Womens Health. 2009; 18(12): 2065-2070.
32. Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005; 61(1): 133-155. doi: 10.1016/j. socscimed.2004.11.063 PMID: 15847968
33. Bonner C, Jansen J, McKinn S, Irwig L, Doust J, Glasziou P, et al. General practitioners' use of different cardiovascular risk assessment strategies: a qualitative study. M J Aust. 2013; 199(7): 485-489.
34. Bonner C, Jansen J, McKinn S, Irwig L, Doust J, Glasziou P, et al. How do general practitioners and patients make decisions about cardiovascular disease risk? Health Psychol. 2015; 34(3): 253-261. doi: 10.1037/hea0000122 PMID: 25133842
35. Bowen GA. Naturalistic inquiry and the saturation concept: a research note. Qual Res. 2008; 8(1): 137-152.
36. Ritchie J, Spencer L, O'Connor W. Carrying out qualitative analysis. In: Ritchie J, Spencer L, editors. Qualitative research practice: a guide for social science students and researchers. London: Sage Publications; 2003. p. 219-262.
37. Barbour RS. Checklists for improving rigour in qualitative research: a case of the tail wagging the dog? BMJ. 2001; 322(7294): 1115-1117. PMID: 11337448
38. Rodriguez-Manas L, Fried LP. Frailty in the clinical scenario. Lancet. 2015; 385(9968): e7-9. doi: 10. 1016/S0140-6736(14)61595-6 PMID: 25468154
39. Savarese G, Gotto AM Jr., Paolillo S, D'Amore C, Losco T, Musella F, et al. Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis. J Am Coll Cardiol. 2013; 62(22): 2090-2099. doi: 10.1016/j.jacc.2013.07.069 PMID: 23954343
40. Kutner JS, Blatchford PJ, Taylor DH Jr., Ritchie CS, Bull JH, Fairclough DL, et al. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial. JAMA Intern Med. 2015; 175(5): 691-700. doi: 10.1001/jamainternmed.2015.0289 PMID: 25798575
41. Schelbert EB, Cao JJ, Sigurdsson S, Aspelund T, Kellman P, Aletras AH, et al. Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. JAMA. 2012; 308(9): 890-896. doi: 10.1001/2012.jama.11089 PMID: 22948699
42. Ramos R, Albert X, Sala J, Garcia-Gil M, Elosua R, Marrugat J, et al. Prevalence and incidence of Qwave unrecognized myocardial infarction in general population: Diagnostic value of the electrocardiogram. The REGICOR study. Int J Cardiol. 2016; 225:300-305. doi: 10.1016/j.ijcard.2016.10.005 PMID: 27744207
43. Van Peet PG, Drewes YM, Gussekloo J, de Ruijter W. GPs' perspectives on secondary cardiovascular prevention in older age: a focus group study in the Netherlands. Br J Gen Pract. 2015 Nov; 65(640): e739-47. doi: 10.3399/bjgp15X687373 PMID: 26500321
44. Collard RM, Boter H, Schoevers RA, Oude Voshaar RC. Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc. 2012; 60(8): 1487-1492. doi: 10.1111/j.1532-5415.2012.04054.x PMID: 22881367
45. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012; 380(9836): 37-43. doi: 10.1016/S0140-6736(12)60240-2 PMID: 22579043
46. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A-Biol. 2001; 56(3): M146-156.
47. Mitnitski AB, Graham JE, Mogilner AJ, Rockwood K. Frailty, fitness and late-life mortality in relation to chronological and biological age. BMC Geriatr. 2002; 2(1): 1.
48. Jansen J, Naganathan V, Carter SM, McLachlan AJ, Nickel B, Irwig L, et al. Too much medicine in older people? Deprescribing through shared decision making. BMJ. 2016; 353: i2893. doi: 10.1136/bmj.i2893 PMID: 27260319